Adversafe offers a proactive approach to identifying possible adverse effects at a very early stage of development. With Adversafe, you no longer need to wait for GLP (Good Laboratory Practice) regulatory toxicology studies to gain an understanding of the safety profile of your compounds at the very early stage. Instead, you can access crucial information quickly and cost-effectively, enabling informed decision-making throughout the drug development process.
By leveraging our expertise in the preclinical pharmacology of pain, Adversafe empowers you to mitigate risk, optimize resources, and accelerate the path to successful drug development.
Proven Testing Strategies: Assessing Safety in Pharmaceuticals
CRITICAL POINTS OF ASSESSMENT
During the development of a drug candidate, early detection of adverse effects is essential, particularly for analgesics.
General behavior
Anxiety
Sedation
Motor coordination
Intestinal transit
Gastropathy
ADVERSAFE: OUR SOLUTION
Adversafe integrates a package of 6 screening tests to provide an early assessment of the critical points of attention when developing a drug candidate.
Irwin grid
Open field
Catalepsy
Rotarod
Charcoal meal
Ulcer detection
Harnessing pharmacological data: Results from our side effects investigations
